AstraZeneca (AZN)
(Delayed Data from NSDQ)
$85.75 USD
+0.03 (0.03%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $85.78 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 24% (61 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.57 | 1.98 | 9.99 |
Current Quarter Estimate | 1.08 | 37.53 | 61.00 |
Year Ago Quarter Estimate | 0.87 | 12.41 | 54.84 |
Next Quarter Estimate | 0.98 | 38.15 | 63.00 |
Next Year Estimate | 4.72 | 172.65 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 11.85 | 6.40 | 15.67 |
Next Year | 16.26 | 16.50 | 11.34 |
Last 5 Years | 14.00 | 2.90 | 8.10 |
Next 5 Years | 13.10 | 11.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 23.68 | 22.60 |
Price/Book (MRQ) | 6.71 | 6.38 |
Price/Cash Flow (MRFY) | 15.88 | 12.28 |
Dividend Yield | 1.14% | 2.01% |
Net Profit Margin (TTM) | 13.11% | 18.86% |
Return on Equity (TTM) | 29.34% | 34.56% |
Debt to Equity (MRQ) | 0.69 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.